Tumor-related molecular mechanisms of oxaliplatin resistance
E Martinez-Balibrea, A Martínez-Cardús, A Ginés… - Molecular cancer …, 2015 - AACR
Oxaliplatin was the first platinum drug with proven activity against colorectal tumors,
becoming a standard in the management of this malignancy. It is also considered for the …
becoming a standard in the management of this malignancy. It is also considered for the …
Biomarkers in cancer staging, prognosis and treatment selection
JA Ludwig, JN Weinstein - Nature Reviews Cancer, 2005 - nature.com
Advances in genomics, proteomics and molecular pathology have generated many
candidate biomarkers with potential clinical value. Their use for cancer staging and …
candidate biomarkers with potential clinical value. Their use for cancer staging and …
Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer
MF Fraga, E Ballestar, A Villar-Garea, M Boix-Chornet… - Nature …, 2005 - nature.com
CpG island hypermethylation and global genomic hypomethylation are common epigenetic
features of cancer cells. Less attention has been focused on histone modifications in cancer …
features of cancer cells. Less attention has been focused on histone modifications in cancer …
The epigenetic progenitor origin of human cancer
Cancer is widely perceived as a heterogeneous group of disorders with markedly different
biological properties, which are caused by a series of clonally selected genetic changes in …
biological properties, which are caused by a series of clonally selected genetic changes in …
Transcriptional regulatory elements in the human genome
GA Maston, SK Evans, MR Green - Annu. Rev. Genomics Hum …, 2006 - annualreviews.org
The faithful execution of biological processes requires a precise and carefully orchestrated
set of steps that depend on the proper spatial and temporal expression of genes. Here we …
set of steps that depend on the proper spatial and temporal expression of genes. Here we …
[HTML][HTML] Aberrant epigenetic landscape in cancer: how cellular identity goes awry
M Berdasco, M Esteller - Developmental cell, 2010 - cell.com
Appropriate patterns of DNA methylation and histone modifications are required to assure
cell identity, and their deregulation can contribute to human diseases, such as cancer. Our …
cell identity, and their deregulation can contribute to human diseases, such as cancer. Our …
Oxidative stress, DNA methylation and carcinogenesis
R Franco, O Schoneveld, AG Georgakilas… - Cancer letters, 2008 - Elsevier
Transformation of a normal cell to a malignant one requires phenotypic changes often
associated with each of the initiation, promotion and progression phases of the carcinogenic …
associated with each of the initiation, promotion and progression phases of the carcinogenic …
Global levels of histone modifications predict prognosis in different cancers
DB Seligson, S Horvath, MA McBrian, V Mah… - The American journal of …, 2009 - Elsevier
Cancer cells exhibit alterations in histone modification patterns at individual genes and
globally at the level of single nuclei in individual cells. We demonstrated previously that …
globally at the level of single nuclei in individual cells. We demonstrated previously that …
Epigenetics in cancer: targeting chromatin modifications
Posttranslational modifications to histones affect chromatin structure and function resulting in
altered gene expression and changes in cell behavior. Aberrant gene expression and …
altered gene expression and changes in cell behavior. Aberrant gene expression and …
Epigenetics and human disease: translating basic biology into clinical applications
D Rodenhiser, M Mann - Cmaj, 2006 - Can Med Assoc
Epigenetics refers to the study of heritable changes in gene expression that occur without a
change in DNA sequence. Research has shown that epigenetic mechanisms provide an" …
change in DNA sequence. Research has shown that epigenetic mechanisms provide an" …